ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,712.69
-0.28%
US Tech 100
19,515.60
0.39%
다우존스 지수
41,794.60
-0.61%
Bitcoin
68,803.31
1.45%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. Celyad Oncology SA (CYAD) 시세

Celyad Oncology SA

Celyad Oncology SA (CYAD)

EU
0.369
0.019
( 5.43% )
업데이트: 18:07:18
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
0.369
매수가
0.3705
매도가
0.369
거래량
28,027
0.369 일간 변동폭 0.372
0.212 52주 범위 0.628
market_cap
15.287M
전일 종가
0.35
개장가
0.369
최근 거래 시간
6000
@
0.369
마지막 거래 시간
17:36:52
재정 규모
-
VWAP
-
평균 볼륨(3m)
22,615
발행 주식
41,429,000
배당수익률
-
주가수익률
-1.81
주당순이익(EPS)
-0.2
매출
102k
순이익
-8.45M

Celyad Oncology SA 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.celyad.com
본부
Mont-saint-guibert, Walloon Brabant, Bel
설립됨
-
Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the 유로넥스트 (Euronext) with ticker CYAD. The last closing price for Celyad Oncology was 0.35 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0.212 € to 0.628 €.

Celyad Oncology currently has 41,429,000 shares in issue. The market capitalisation of Celyad Oncology is 14.50 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -1.81.

CYAD 최신 뉴스

추가 뉴스

Celyad Oncology Présentera au Congrès Annuel SITC 2024

Regulatory News: Celyad Oncology (Euronext: CYAD) (la “Société”), annonce aujourd'hui la présentation de deux posters lors de la 39e réunion annuelle de la Society for Immunotherapy of Cancer...

08 10월 2024
Business Wire

Celyad Oncology announces intention to terminate SEC reporting obligations

MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with...

09 2월 2024
GlobeNewswire Inc.

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...

17 1월 2024
GlobeNewswire Inc.

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces, in accordance with Article 14 of the...

21 12월 2023
GlobeNewswire Inc.

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces that 6,500,000 shares of CFIP CLYD (UK...

16 12월 2023
GlobeNewswire Inc.

Celyad announces management change

MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of...

05 12월 2023
GlobeNewswire Inc.

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance...

01 12월 2023
GlobeNewswire Inc.

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the...

22 11월 2023
GlobeNewswire Inc.

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces the below information following the...

15 11월 2023
GlobeNewswire Inc.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.10640.30418250950.2630.3720.2615521610.3222625DE
40.082528.79581151830.28650.3720.25216810.29986073DE
120.12953.750.240.3720.212226150.26812122DE
260.05417.14285714290.3150.3720.212174340.27476363DE
52-0.259-41.24203821660.6280.6280.212256250.36334694DE
156-3.281-89.89041095893.654.60.212361541.49285576DE
260-8.931-96.03225806459.312.260.212413254.30220419DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ALACTActicor Biotech
0.58 €
(28.89%)
39.43k
ALDOLDolfines
0.0006 €
(20.00%)
141k
DMSBSDiagnostic Medical Systems
0.003 €
(20.00%)
50
PHXMPHAXIAM Therapeutics SA
1.95 €
(19.34%)
114.5k
CNVCnova NV
0.15 €
(15.38%)
4.17k
ALSRSSirius Media
0.0171 €
(-26.92%)
947.39k
ALTHOMetavisio (Thomson Computing)
0.1852 €
(-15.63%)
903.96k
S30Solutions 30 SE
1.127 €
(-6.94%)
1.16M
ALGROGrolleau SA
3.62 €
(-6.70%)
57
ALDUBEncres Dubuit
2.52 €
(-6.67%)
3.06k
BCPBanco Comercial Portugues SA
0.4582 €
(1.60%)
11.4M
ALTDTonner Drones
0.0088 €
(-2.22%)
6.03M
ALHPIHopium SA
0.0121 €
(10.00%)
4.58M
ALNEVNeovacs
0.0003 €
(0.00%)
4.33M
ALAVEAventador
0.0012 €
(0.00%)
2.24M

토론

전체 피드 보기
Bull_Dolphin Bull_Dolphin 7 분 전
Rogan endorses:

Joe Rogan Endorses Trump After Discussing ‘Most Compelling Case For Trump You’ll Hear’ With Elon Musk
By: Breccan F. Thies
November 04, 2024

https://thefederalist.com/wp-content/uploads/2024/11/Screenshot-2024-11-04-224223-1200x675.jpg
weedtrader420 weedtrader420 11 분 전
D.O.G.E. X WOOHOOOOOOOOOOOOOOO ✊😎
DOGEUSD
Alexulf Alexulf 38 분 전
AITX - RAD Team Challenge Coins: Celebrating
Innovation & Dedication Across the Globe

Last week this video came out, exciting :-)

https://youtu.be/gGAfs8iWJDw
AITX
TradingCharts TradingCharts 42 분 전
Quebec Mining Act reform
Francois Brabant and David Gravel
| October 29, 2024
https://www.canadianminingjournal.com/featured-article/quebec-mining-act-reform/
Swampy83 Swampy83 54 분 전
Prestigious to whom? The POS has not moved since mid October, dilution has not stop since mid Oct.We have not heard anything regarding the cancelation of 1.7B shares, probably a fraction of what was added.
In fact we haven't heard anything at all...
RDAR
Ranb2khz Ranb2khz 1 시간 전
I Believe It (The Life of Jesus) – Jon Reddick (Lyric Video)

[yt]WzIRyHzC06c[/yt]

https://www.youtube.com/watch?v=WzIRyHzC06c






•
Investor2014 Investor2014 1 시간 전
Georgejjl, I want to congratulate you on $AVXL actually closing near the high of trading day yesterday in a convincing manor. Enjoy the dopamine rush and may there be many more to help averaging down your many failed $AVXL predictions.
AVXL
Augster Augster 1 시간 전
Smart move, and said they will use same standards required for future regulatory filings. Makes sense to me. It’s a world wide market, US is one part of it, will help millions around the world. Mayo Clinic is has networks around the globe!
RDGL
snow snow 1 시간 전
I ll be back Thanks! I am optimistic but I hardly slept tonight because I was not sleepy.
SPZI
eagle8 eagle8 1 시간 전
Thanks for this addition to Peter Davis' post Doc logic.
Sorry my response to your mail is a bit late but I was very busy yesterday.
I (almost of course) agree with you.
I was also pleasantly surprised by the news about one leg - cancer trials with tumor shrinkage as a kind of m
NWBO
north40000 north40000 1 시간 전
"Amarin is the Blackberry of drug companies." Not such a bad fate for Amarin,  style="font-size: 1em"maybe. I've been following Blackberry for years, and its software that is still among the best for security-- military use, renewal of tank and other military vehicle contracts. I think that software
CDMO NVO PLTR
bbotcs bbotcs 1 시간 전
Next 24 hours--the eye of the hurricane.
LVerstee LVerstee 2 시간 전
...
https://investorshub.advfn.com/uimage/uploads/2024/11/1/mmlvdjerry-maguire-show-me-the-money.gif
ITUP
The Danish Dude The Danish Dude 2 시간 전
No my little lying corrupt paid shill, they have not. Neither have they passed on DCVax-L of which you and all others are completely clueless, nor are they a sponsor.

Read my lips. THEY ARE NOT A SPONSOR. Read the clinical trial.

https://pbs.twimg.com/media/GbOJlh3XwAA
NWBO
Swampy83 Swampy83 2 시간 전
That's what I have been thinking and that is what scares me.
RDAR
beacham beacham 2 시간 전
It does a very good job of explaining the product and the technology behind it. It was packaged w/ the General's video testimony, another great video that never gets old to watch again. I still think it is really weird and quirky (not in a good way, either) w/ the characters having no face, hands, o
BIEL
$$$83 $$$83 2 시간 전
So next earnings should be released later this month I assume , the past few quarters revenue was low ,looking fwd to an outlook that guarantees current investors confidence in it long-term
SEV
$$$83 $$$83 2 시간 전
So next earnings should be released later this month I assume , the past few quarters revenue was low ,looking fwd to an outlook that guarantees current investors confidence in it long-term
SEV
SiliconValleyExec SiliconValleyExec 2 시간 전
Bankruptcy is protection against debt. S7 does not hold any debt and therefore would not need bankruptcy protection. Please have your facts straight before messaging falsehoods.
SEV
wallstreet1231 wallstreet1231 2 시간 전
Isn’t it time you start asking the tough questions, like why is this subject being left up to speculation, instead of cheerleading an opinionated narrative. Lots of questions that shareholders need to push for answers, don’t get sucked into the speculation game. Speculation merely takes the pressur
SNPW

최근 히스토리

EU
CYAD
Celyad Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유